Visicu (MM) (NASDAQ:EICU)
Historical Stock Chart
From Jun 2019 to Jun 2024
VISICU, Inc. (Nasdaq:EICU), a healthcare information technology and
clinical solutions company focused on transforming the delivery of care
to the highest acuity patients in the hospital, today announced
financial results for the second quarter of 2007. The company reported
significantly higher revenue and operating income for the second quarter
over the same quarter from the prior year:
Revenue for the second quarter was $9.1 million, a 20% increase over
the same quarter last year.
Adjusted operating income for the second quarter increased to $2.5
million, resulting in a 27% adjusted operating margin, from adjusted
operating income of $1.8 million and an adjusted operating margin of
24% for the same quarter last year. Adjusted operating income and
adjusted operating margin exclude non-cash stock-based compensation
expense included in the GAAP results.
GAAP operating income for the second quarter increased to $1.7
million, resulting in a 19% operating margin, from GAAP operating
income of $1.1 million and operating margin of 15% for the same
quarter last year. GAAP operating income includes non-cash stock-based
compensation expense of $741,000 and $658,000 in the second quarter of
2007 and 2006, respectively.
Net income for the second quarter of 2007 increased to $2.1 million,
or $0.06 per diluted share, from $1.2 million, or $0.04 per diluted
share for the same quarter last year.
Total revenue backlog at the end of the second quarter was $63.8
million.
“We are pleased with our strong operating
results and financial position, and we are focused on investing
resources to execute on sales and marketing initiatives to accelerate
market adoption,” said Frank Sample, Chairman
and CEO of VISICU. “We have yet to reach the
tipping point in the market and are in the midst of transitioning from
early adopters to the early majority. This has lengthened our sales
cycle and impacted year to date new account sales activity. Although our
backlog has decreased, we are experiencing increased market interest for
our solution and our sales pipeline is expanding. As a result, I am very
optimistic about the mid to long term growth prospects for the business.”
Conference Call Information
A conference call and audio webcast will be held today, Thursday, July,
26, 2007 at 4:30 p.m. EST. Participants can access the call by dialing
719-457-2651 or access the audio webcast directly at http://investors.visicu.com/eventdetail.cfm?eventid=42218
or through the company's website at www.VISICU.com.
A replay of the call will be available approximately three hours after
the call has ended and will be available until 11:59 p.m. (EDT) on
Thursday, August 2, 2007. To access the replay, dial 719-457-0820 and
enter the conference passcode number: 8623384. A replay will also be
archived online on the company's corporate website at www.VISICU.com.
About VISICU, Inc.
VISICU, Inc. is a healthcare information technology and clinical
solutions company transforming the delivery of critical care through its
eICU Program. The eICU Program restructures the practice of critical
care by using remote monitoring technology to allow systems to
centralize scarce critical care trained staff to improve coverage and to
allow intervention to prevent or manage crises. For more information,
visit www.VISICU.com. VISICU®
and eICU® are registered trademarks of VISICU,
Inc. All rights reserved. visicu-f
Safe Harbor Statement
This release contains forward-looking statements that are made pursuant
to the provisions of Section 21E of the Securities and Exchange Act of
1934, as amended. These forward-looking statements involve a number of
risks and uncertainties. Investors are cautioned that statements in this
press release that are not strictly historical statements constitute
forward-looking statements. It is important to note that the company’s
performance, and actual results, financial condition or business could
differ materially from those expressed in the forward-looking
statements. The words “outlook”,
“positions us”, “guidance”,
“expects”, “estimates”,
“intends”, “plans”,
“projects”, “anticipates”,
“believes” or the
negative of these words, variations thereof or similar expressions are
intended to identify such forward-looking statements. Factors that could
cause or contribute to such differences include, but are not limited to:
market acceptance of the company’s principal
product offering and any new product releases, the performance and
reliability of our products and services, the company’s
ability to attract and retain new customers, renewal rates of the company’s
existing customers, financial and budget constraints of hospitals,
changes in the company’s or competitors’
pricing practices, quarterly operating results may vary, stock price may
be volatile, changes in the healthcare industry, the introduction or
availability of competing products or services and other competitive
factors, changes in the government regulation of our products and
services, and the possibility of unfavorable outcomes in regulatory and
legal proceedings relating to VISICU's patent that are pending currently
or that could be initiated in the future. Additional discussion of these
and other factors affecting the company’s
business is contained in the company’s
periodic filings with the Securities and Exchange Commission. The
company undertakes no obligation to update forward-looking statements to
reflect changed assumptions the occurrence of unanticipated events or
changes in future operating results, financial condition or business
over time.
Use of Non-GAAP Financial Measures
Adjusted operating income (loss) and adjusted operating margins as
described in this release and in the attached financial statement tables
are not measures of financial performance under generally accepted
accounting principles (GAAP) and should not be considered a substitute
for or superior to GAAP operating income (loss) and operating margins.
Management believes the non-GAAP results provide useful information to
both management and investors by excluding certain expenses that may not
be indicative of our core results and provides for consistency in
financial reporting. Management provides these non-GAAP financial
measures because it believes they provide greater transparency with
respect to supplemental information used by management in its financial
and operational decision making. Specifically, these non-GAAP measures
are provided to enhance investor's overall understanding of the company’s
current financial performance and the company’s
future prospects. For the reconciliation of adjusted operating income
(loss) and operating margins to GAAP, please refer to the information
included in the attached tables of this press release.
Visicu, Inc.
Condensed Statements of Operations
(In thousands, except per share data)
(Unaudited)
Three Months Ended
Six Months Ended
June 30,
June 30,
2006
2007
2006
2007
Revenues
$
7,529
$
9,054
$
14,198
$
17,794
Direct cost of revenues
1,438
1,717
2,841
3,363
Gross profit
6,091
7,337
11,357
14,431
Operating expenses
4,975
5,601
9,789
11,283
Income from operations
1,116
1,736
1,568
3,148
Interest income
1,185
1,667
1,325
3,299
Interest expense
(2
)
(1
)
(4
)
(7
)
Income before income taxes
2,299
3,402
2,889
6,440
Income tax expense
1,056
1,271
1,332
2,336
Net income
$
1,243
$
2,131
$
1,557
$
4,104
Net income per share:
Basic
$
0.04
$
0.07
$
0.09
$
0.13
Diluted
$
0.04
$
0.06
$
0.05
$
0.12
Weighted-average shares outstanding used in computing per share
amounts:
Basic
29,080
32,516
17,305
32,502
Diluted
33,844
34,391
30,799
34,541
Visicu, Inc.
Reconciliation Between GAAP and Adjusted Operating Income
(In thousands)
(Unaudited)
Three Months Ended June 30,
2006
2007
Income from operations
$
1,116
$
1,736
Non-cash stock-based compensation
658
741
Adjusted income from operations
$
1,774
$
2,477
Visicu, Inc.
Reconciliation Between GAAP and Adjusted Operating Income
(In thousands)
(Unaudited)
Six Months Ended June 30,
2006
2007
Income from operations
$
1,568
$
3,148
Non-cash stock-based compensation
1,229
1,426
Adjusted income from operations
$
2,797
$
4,574
Visicu, Inc.
Condensed Balance Sheets
(In thousands)
December 31,
June 30,
2006
2007
(Unaudited)
Assets
Current assets:
Cash and cash equivalents
$
74,188
$
102,873
Marketable securities
46,047
26,900
Accounts receivable
11,465
5,789
Prepaid expenses and other current assets
1,686
1,182
Deferred tax assets
7,915
6,644
Total current assets
141,301
143,388
Property and equipment, net
1,631
1,561
Deferred contract costs
4,477
4,406
Marketable securities
2,960
-
Deferred tax assets
6,140
6,073
Other assets
503
438
Total assets
$
157,012
$
155,866
Liabilities and stockholders’ equity
Current liabilities:
Accounts payable and accrued expenses
$
1,244
$
849
Accrued compensation and related costs
1,581
1,374
Deferred revenue
30,290
26,616
Other current liabilities
27
27
Total current liabilities
33,142
28,866
Other long-term liabilities
468
369
Deferred revenue
19,074
14,944
Total liabilities
52,684
44,179
Stockholders’ equity
104,328
111,687
Total liabilities and stockholders’ equity
$
157,012
$
155,866
Visicu, Inc.
Condensed Statements of Cash Flows
(In thousands)
(Unaudited)
Six Months Ended June 30,
2006
2007
Net income
$
1,557
$
4,104
Adjustments to reconcile net income to net cash provided by
operating activities
2,336
1,879
Changes in operating assets and liabilities
1,495
(864
)
Net cash provided by operating activities
5,388
5,119
Purchases of property and equipment
(245
)
(354
)
Maturities (purchases) of marketable securities
(19,014
)
22,107
Other investing activity changes
(7
)
(179
)
Net cash provided by (used in) investing activities
(19,266
)
21,574
Proceeds from issuance of common stock, net of costs
100,720
-
Exercise of options to purchase common stock
792
551
Excess tax benefit from stock-based compensation
113
1,453
Other financing activity changes
(12
)
(12
)
Net cash provided by financing activities
101,613
1,992
Net increase in cash and cash equivalents
87,735
28,685
Cash and cash equivalents at beginning of period
11,379
74,188
Cash and cash equivalents at end of period
$
99,114
$
102,873